A detailed history of Richmond Brothers, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Richmond Brothers, Inc. holds 1,097,016 shares of MDXG stock, worth $7.6 Million. This represents 16.05% of its overall portfolio holdings.

Number of Shares
1,097,016
Previous 1,404,352 21.88%
Holding current value
$7.6 Million
Previous $12.3 Million 31.41%
% of portfolio
16.05%
Previous 21.71%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$7.61 - $8.63 $2.34 Million - $2.65 Million
-307,336 Reduced 21.88%
1,097,016 $8.45 Million
Q4 2023

Feb 08, 2024

SELL
$5.7 - $9.14 $438,786 - $703,597
-76,980 Reduced 5.2%
1,404,352 $12.3 Million
Q3 2023

Nov 02, 2023

SELL
$6.35 - $8.16 $667,816 - $858,170
-105,168 Reduced 6.63%
1,481,332 $10.8 Million
Q2 2023

Aug 11, 2023

SELL
$3.14 - $6.61 $529,488 - $1.11 Million
-168,627 Reduced 9.61%
1,586,500 $10.5 Million
Q1 2023

May 10, 2023

SELL
$2.97 - $4.81 $1.37 Million - $2.22 Million
-461,693 Reduced 20.83%
1,755,127 $5.98 Million
Q4 2022

Feb 07, 2023

SELL
$2.63 - $3.45 $756,301 - $992,106
-287,567 Reduced 11.48%
2,216,820 $6.16 Million
Q3 2022

Nov 01, 2022

SELL
$2.71 - $4.22 $100,703 - $156,815
-37,160 Reduced 1.46%
2,504,387 $7.18 Million
Q2 2022

Aug 12, 2022

SELL
$3.17 - $5.0 $10,803 - $17,040
-3,408 Reduced 0.13%
2,541,547 $8.81 Million
Q1 2022

May 05, 2022

SELL
$4.27 - $6.27 $168,203 - $246,987
-39,392 Reduced 1.52%
2,544,955 $12 Million
Q4 2021

Feb 10, 2022

BUY
$5.7 - $8.48 $14.7 Million - $21.9 Million
2,584,347 New
2,584,347 $15.6 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $787M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Richmond Brothers, Inc. Portfolio

Follow Richmond Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.